Federal regulators say MedImmune’s nasal spray flu vaccine is effective for children under age 5 even though it may increase the risk of respiratory problems.
The vaccine, Flumist, was once thought to be a possible blockbuster drug, but has had modest sales because approved use is limited to healthy people between the age of 5 and 49 years old.
Source: FoxNews.com